Product Information
AMITRIPTYLINE HCL 100 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1506 per EA under NDC 16571010901. Its NADAC has been published 139 times since Nov 1, 2023.
Strength
100 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571010901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217411On Market Since
6/10/2023
Pharmacological Classes
Price Statistics
The NADAC for AMITRIPTYLINE HCL 100 MG TAB has been published 139 times since Nov 1, 2023, and over the history we have for it it has declined 10.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1506 per EA |
|---|---|
| All-time high | $0.1997 (Apr 10, 2024) |
| All-time low | $0.1180 (Nov 20, 2024) |
| 52-week high | $0.1773 |
| 52-week low | $0.1506 |
| Median price | $0.1626 |
| Average price | $0.1577 |
| Largest weekly change | -34.6% (Apr 17, 2024) |
| Weeks tracked | 139 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMITRIPTYLINE HCL 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 100 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.1506 per EA (NDC 16571010901), effective Jun 24, 2026.
How has the price of AMITRIPTYLINE HCL 100 MG TAB changed over time?
Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 100 MG TAB has declined 10.1%. It has been tracked across 139 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 100 MG TAB?
Since Nov 1, 2023, the NADAC for AMITRIPTYLINE HCL 100 MG TAB has ranged from a low of $0.1180 (Nov 20, 2024) to a high of $0.1997 (Apr 10, 2024), with a median of $0.1626 per EA.
Are there cheaper alternatives to AMITRIPTYLINE HCL 100 MG TAB?
9 NADAC-published products share the same active ingredient, strength, and dosage form as AMITRIPTYLINE HCL 100 MG TAB, but none are currently priced below it.
Who manufactures AMITRIPTYLINE HCL 100 MG TAB?
AMITRIPTYLINE HCL 100 MG TAB (NDC 16571010901) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification